Saly Medical: As of August 5th, no shares repurchased have been sold off.

Celer Medical announced that the company had repurchased shares twice in 2024, totaling 3,977,700 shares, accounting for 1.76% of the total equity. On May 9, 2026, the company disclosed a reduction plan, intending to sell no more than 3,977,700 repurchased shares within six months. As of August 5, the company has not sold the aforementioned repurchased shares. There is uncertainty and risk associated with the reduction, and the company will fulfill its information disclosure obligations in a timely manner as required.